{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:34:42Z","timestamp":1774863282763,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1067\/mhj.2002.120774","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T21:24:11Z","timestamp":1034198651000},"page":"753-759","source":"Crossref","is-referenced-by-count":133,"title":["Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes"],"prefix":"10.1067","volume":"143","author":[{"given":"Richard C.","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Sanderink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott M.","family":"Antman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2002.120774_bib1","first-page":"242-50","article-title":"The pathophysiology of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.120774_bib2","first-page":"154","article-title":"Unstable angina: diagnosis and management","author":"Braunwald","year":"1994"},{"key":"10.1067\/mhj.2002.120774_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V79.1.1.1","article-title":"Low molecular weight heparin","volume":"79","author":"Hirsh","year":"1993","journal-title":"Blood"},{"key":"10.1067\/mhj.2002.120774_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0272-6386(98)70074-5","article-title":"Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey","volume":"32","author":"Jones","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"1 Suppl","key":"10.1067\/mhj.2002.120774_bib5","first-page":"S67","article-title":"US Renal Data System","volume":"30","author":"The USRDS Dialysis Morbidity","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mhj.2002.120774_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.V76889","article-title":"Risk factors for hospital utilization in chronic dialysis patients","volume":"7","author":"Rocco","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1067\/mhj.2002.120774_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-110-5-369","article-title":"Coronary artery bypass surgery in patients in chronic hemodialysis: a case-control study","volume":"110","author":"Deutsch","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2002.120774_bib8","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0003-4975(94)91671-3","article-title":"Coronary artery bypass grafting in patients with dialysis-dependent renal failure","volume":"58","author":"Owen","year":"1994","journal-title":"Ann Thorac Surg"},{"issue":"2 Suppl","key":"10.1067\/mhj.2002.120774_bib9","first-page":"II38","article-title":"Coronary artery bypass grafting in patients with non-dialysis dependent renal insufficiency","volume":"96","author":"Rao","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.120774_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.90.4.1624","article-title":"Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in acute Myocardial Infarction (TIMI) 9A Trial","volume":"90","author":"Antman","year":"1994","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.120774_bib11","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0735-1097(97)00094-6","volume":"29","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.120774_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0049-3848(76)90034-7","article-title":"Assay of heparin in plasma using a chromogenic substrate for activated factor X","volume":"8","author":"Teien","year":"1976","journal-title":"Thromb Res"},{"key":"10.1067\/mhj.2002.120774_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2007-1004366","article-title":"Practical considerations on the measurement of low molecular weight heparin and anti-Xa activity","volume":"11","author":"Aich","year":"1985","journal-title":"Semin Thromb Haemost"},{"key":"10.1067\/mhj.2002.120774_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1067\/mhj.2002.120774_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low molecular weight heparin during instability in coronary artery disease","volume":"347","author":"Fragmin-During-Instability-In-Coronary-Artery-Disease Study Group","year":"1996","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.120774_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","article-title":"Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study","volume":"96","author":"Klein","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.120774_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.120774_bib18","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.120774_bib19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction","volume":"36","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.120774_bib20","first-page":"1S","volume":"119","year":"2001"},{"key":"10.1067\/mhj.2002.120774_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/clc.4960210504","article-title":"Management strategies for a better outcome in unstable coronary artery disease","volume":"21","author":"Campbell","year":"1998","journal-title":"Clin Cardiol"},{"key":"10.1067\/mhj.2002.120774_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198405033101801","article-title":"Thrombosis and acute coronary lesions in sudden ischemic cardiac deaths","volume":"310","author":"Davies","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.120774_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.71.4.699","article-title":"Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and\/or sudden death","volume":"71","author":"Falk","year":"1985","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.120774_bib24","first-page":"1330","article-title":"The role of the membrane in the expression of the vitamin K-dependent enzymes","volume":"116","author":"Mann","year":"1992","journal-title":"Arch Pathol Lab Med"},{"key":"10.1067\/mhj.2002.120774_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1018710526772","article-title":"Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor Xa neutralization","volume":"9","author":"Spencer","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"10.1067\/mhj.2002.120774_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(93)91139-9","article-title":"Comparison of the efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects","volume":"72","author":"Melandri","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2002.120774_bib27","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/01.CIR.91.8.2188","article-title":"Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans","volume":"91","author":"Dehmer","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.120774_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0038-1648988","article-title":"Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis \u201cin vivo\u201d","volume":"72","author":"Landolfi","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2002.120774_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0038-1642434","article-title":"Ex vivo and in vitro evidence that low molecular weight heparin exhibits less binding to plasma proteins than unfractionated heparin","volume":"71","author":"Young","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2002.120774_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2165\/00003088-198916010-00003","article-title":"Saturable pharmacokinetics in the renal excretion of drugs","volume":"16","author":"van Ginneken","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1067\/mhj.2002.120774_bib31","first-page":"417","article-title":"Pharmacokinetics of standard and low molecular weight heparin","author":"Albada","year":"1989"},{"key":"10.1067\/mhj.2002.120774_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/bj2380329","article-title":"The relative molecular mass dependence of the anti-factor Xa properties of heparin","volume":"238","author":"Ellis","year":"1986","journal-title":"Biochem J"},{"key":"10.1067\/mhj.2002.120774_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0950-3536(05)80017-4","article-title":"Pharmacokinetics of heparin and low molecular weight heparins","volume":"3","author":"Boneu","year":"1990","journal-title":"Baillieres Clin Haematol"},{"key":"10.1067\/mhj.2002.120774_bib34","first-page":"30","article-title":"Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin","volume":"16","author":"Holm","year":"1986","journal-title":"Haemostasis"},{"key":"10.1067\/mhj.2002.120774_bib35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.101.10.1083","article-title":"Low molecular weight heparin after mechanical heart valve replacement","volume":"101","author":"Montalescot","year":"2000","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.120774_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0049-3848(85)90357-3","article-title":"Disappearance of circulating anti-Xa activity after intravenous injection of standard heparin and of low molecular weight heparin (CY 216) in normal and binephrectomized rabbits","volume":"40","author":"Caranobe","year":"1985","journal-title":"Thromb Res"},{"key":"10.1067\/mhj.2002.120774_bib37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/s-0038-1646018","article-title":"Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance","volume":"58","author":"Palm","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2002.120774_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0049-3848(91)90141-I","article-title":"Delayed elimination of enoxaparin in patients with chronic renal insufficiency","volume":"63","author":"Cadroy","year":"1991","journal-title":"Thromb Res"},{"key":"10.1067\/mhj.2002.120774_bib39","first-page":"147","article-title":"Pharmacokinetic studies of standard heparin and low molecular weight heparin in patients with chronic renal failure","volume":"16","author":"Follea","year":"1986","journal-title":"Haemostasis"},{"key":"10.1067\/mhj.2002.120774_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(86)90039-3","article-title":"Low molecular weight heparin half-life is prolonged in haemodialysed patients","volume":"43","author":"Goudable","year":"1986","journal-title":"Thromb Res"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302022962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302022962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T22:51:53Z","timestamp":1622242313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870302022962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0002870302022962"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2002.120774","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}